• Explore /
  • Poster
  • / Multicenter observational study of nanoliposomal irinotecan and fluorouracil/leucovorin in patients with unresectable or recurrent pancreatic cancer (NAPOLEON-2): Final retrospective results.

Multicenter observational study of nanoliposomal irinotecan and fluorouracil/leucovorin in patients with unresectable or recurrent pancreatic cancer (NAPOLEON-2): Final retrospective results.

Abstract Poster

Authors

null

Takashi Imajima

Sasebo Kyosai Hospital, Fukuoka, Japan;

Takashi Imajima , Tsuyoshi Shirakawa , Mototsugu Shimokawa , Taiga Otsuka , Taro Shibuki , Junichi Nakazawa , Shiho Arima , Keisuke Miwa , Futa Koga , Yoshihito Kubotsu , Yujiro Ueda , Ayumu Hosokawa , Shigeyuki Takeshita , Hozumi Shimokawa , Azusa Komori , Hisanobu Oda , Tatsunori Sakai , Shuji Arita , Toshihiko Mizuta , Kenji Mitsugi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 706)

DOI

10.1200/JCO.2023.41.4_suppl.706

Abstract #

706

Poster Bd #

K13

Abstract Disclosures

Similar Posters

Poster

2019 Gastrointestinal Cancers Symposium

FOLFIRINOX in pancreatic cancer patients age 75 years or older.

FOLFIRINOX in pancreatic cancer patients age 75 years or older.

First Author: Jonathan Mizrahi

First Author: Masato Ozaka

First Author: Changhoon Yoo

First Author: Andrew Peter Dean